Market closed
Quest Diagnostics/DGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Quest Diagnostics
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Ticker
DGX
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
50,000
Website
DGX Metrics
BasicAdvanced
$18B
Market cap
21.13
P/E ratio
$7.44
EPS
0.89
Beta
$2.96
Dividend rate
1.91%
Dividend yield
Price and volume
Market cap
$18B
Beta
0.89
52-week high
$157.34
52-week low
$120.87
Average daily volume
749K
Dividend rate
$2.96
Financial strength
Current ratio
1.254
Quick ratio
1.023
Long term debt to equity
89.452
Total debt to equity
100.708
Dividend payout ratio (TTM)
38.88%
Interest coverage (TTM)
7.16%
Management effectiveness
Return on assets (TTM)
5.65%
Return on equity (TTM)
13.22%
Valuation
Price to earnings (TTM)
21.128
Price to revenue (TTM)
1.832
Price to book
2.58
Price to tangible book (TTM)
-5.01
Price to free cash flow (TTM)
17.087
Dividend yield (TTM)
1.88%
Forward dividend yield
1.91%
Growth
Revenue change (TTM)
2.60%
Earnings per share change (TTM)
11.56%
3-year revenue growth (CAGR)
-4.77%
3-year earnings per share growth (CAGR)
-23.53%
3-year dividend per share growth (CAGR)
6.94%
What the Analysts think about DGX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Quest Diagnostics stock.
DGX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
DGX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
DGX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Quest Diagnostics stock?
Quest Diagnostics (DGX) has a market cap of $18B as of October 24, 2024.
What is the P/E ratio for Quest Diagnostics stock?
The price to earnings (P/E) ratio for Quest Diagnostics (DGX) stock is 21.13 as of October 24, 2024.
Does Quest Diagnostics stock pay dividends?
Yes, the Quest Diagnostics (DGX) stock pays dividends to shareholders. As of October 24, 2024, the dividend rate is $2.96 and the yield is 1.91%. Quest Diagnostics has a payout ratio of 38.88% on a trailing twelve-month basis.
When is the next Quest Diagnostics dividend payment date?
The next Quest Diagnostics (DGX) dividend payment date is unconfirmed.
What is the beta indicator for Quest Diagnostics?
Quest Diagnostics (DGX) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.